MedPath

TABLETS (INDIA) LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

10

Active:0
Completed:4

Trial Phases

2 Phases

Phase 4:8
Not Applicable:2

Drug Approvals

8

PHILIPPINES:8

Drug Approvals

Gentimin

Approval Date
Jul 14, 2025
PHILIPPINES

Neovis

Approval Date
Jul 14, 2025
PHILIPPINES

Nostigmine

Approval Date
Jul 14, 2025
PHILIPPINES

Stigmithyl

Approval Date
Jul 14, 2025
PHILIPPINES

Neostilex

Approval Date
Jul 14, 2025
PHILIPPINES

Genstigmine

Approval Date
Jul 14, 2025
PHILIPPINES

Gostigmine

Approval Date
Jul 14, 2025
PHILIPPINES

Stigmasan

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 4
8 (80.0%)
Not Applicable
2 (20.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.